checkpoint inhibitors

Showing 1 posts of 1 posts found.

shutterstock_360472550

Higher mutational burdens in tumours linked to greater immunotherapy success, study finds

December 21, 2017
Research and Development Cancer, Johns Hopkins Kimmel Cancer Center, checkpoint inhibitors, mutational burden, pharma

New research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Cancer Institute for Cancer Immunotherapy has indicated that …

The Gateway to Local Adoption Series

Latest content